 Immunoassay
"Immunoassay" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A technique using antibodies for identifying or quantifying a substance. Usually the substance being studied serves as antigen both in antibody production and in measurement of antibody by the test substance.
| Descriptor ID |
D007118
|
| MeSH Number(s) |
E05.478.566 E05.601.470
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Immunoassay".
Below are MeSH descriptors whose meaning is more specific than "Immunoassay".
This graph shows the total number of publications written about "Immunoassay" by people in this website by year, and whether "Immunoassay" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 | | 1997 | 0 | 1 | 1 | | 1998 | 0 | 1 | 1 | | 2001 | 1 | 0 | 1 | | 2003 | 1 | 2 | 3 | | 2005 | 1 | 2 | 3 | | 2006 | 1 | 1 | 2 | | 2007 | 0 | 2 | 2 | | 2008 | 1 | 2 | 3 | | 2010 | 1 | 6 | 7 | | 2011 | 1 | 1 | 2 | | 2012 | 2 | 4 | 6 | | 2013 | 1 | 4 | 5 | | 2014 | 2 | 0 | 2 | | 2015 | 0 | 1 | 1 | | 2016 | 2 | 2 | 4 | | 2017 | 1 | 4 | 5 | | 2018 | 0 | 3 | 3 | | 2020 | 2 | 3 | 5 | | 2021 | 2 | 2 | 4 | | 2022 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Immunoassay" by people in Profiles.
-
Pepper MA, Wiredja DD, Patel PM, Stevens BA, Pinsky BA, Shi RZ. A spurious positive result on the Abbott Architect 4th generation HIV Ag/Ab combo assay in a low-risk patient. Clin Chim Acta. 2022 06 01; 531:386-388.
-
Frazer-Abel A, Kirschfink M, Proh?szka Z. Expanding Horizons in Complement Analysis and Quality Control. Front Immunol. 2021; 12:697313.
-
Huey L, Andersen G, Merkel PA, Morrison TE, McCarthy M, DomBourian MG, Annen K, Dawson ED, Rowlen KL, Knight V. Evaluation of a multiplexed coronavirus antigen array for detection of SARS-CoV-2 specific IgG in COVID-19 convalescent plasma. J Immunol Methods. 2021 10; 497:113104.
-
Schultz JS, McCarthy MK, Rester C, Sabourin KR, Annen K, DomBourian M, Eisenmesser E, Frazer-Abel A, Knight V, Jaenisch T, Morrison TE, Rochford R, Kedl RM. Development and Validation of a Multiplex Microsphere Immunoassay Using Dried Blood Spots for SARS-CoV-2 Seroprevalence: Application in First Responders in Colorado, USA. J Clin Microbiol. 2021 05 19; 59(6).
-
Nisar MI, Ansari N, Khalid F, Amin M, Shahbaz H, Hotwani A, Rehman N, Pugh S, Mehmood U, Rizvi A, Memon A, Ahmed Z, Ahmed A, Iqbal J, Saleem AF, Aamir UB, Larremore DB, Fosdick B, Jehan F. Serial population-based serosurveys for COVID-19 in two neighbourhoods of Karachi, Pakistan. Int J Infect Dis. 2021 May; 106:176-182.
-
Dawson ED, Kuck LR, Blair RH, Taylor AW, Toth E, Knight V, Rowlen KL. Multiplexed, microscale, microarray-based serological assay for antibodies against all human-relevant coronaviruses. J Virol Methods. 2021 05; 291:114111.
-
Basile AJ, Horiuchi K, Goodman CH, Kosoy O, Panella AJ, Velez JO, Pastula DM, Brault AC, Staples JE, Calvert AE. Development of diagnostic microsphere-based immunoassays for Heartland virus. J Clin Virol. 2021 01; 134:104693.
-
Krsak M, Johnson SC, Poeschla EM. COVID-19 Serosurveillance May Facilitate Return-to-Work Decisions. Am J Trop Med Hyg. 2020 06; 102(6):1189-1190.
-
Raffield LM, Dang H, Pratte KA, Jacobson S, Gillenwater LA, Ampleford E, Barjaktarevic I, Basta P, Clish CB, Comellas AP, Cornell E, Curtis JL, Doerschuk C, Durda P, Emson C, Freeman CM, Guo X, Hastie AT, Hawkins GA, Herrera J, Johnson WC, Labaki WW, Liu Y, Masters B, Miller M, Ortega VE, Papanicolaou G, Peters S, Taylor KD, Rich SS, Rotter JI, Auer P, Reiner AP, Tracy RP, Ngo D, Gerszten RE, O'Neal WK, Bowler RP. Comparison of Proteomic Assessment Methods in Multiple Cohort Studies. Proteomics. 2020 06; 20(12):e1900278.
-
Schniedewind B, Meyer EJ, Christians U. Long-Term Performance of Laboratory-Developed Liquid Chromatography-Tandem Mass Spectrometry Tests and a Food and Drug Administration-Approved Immunoassay for the Therapeutic Drug Monitoring of Everolimus. Ther Drug Monit. 2020 06; 42(3):421-426.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|